483
Baxter Oncology GmbHFDA 483 - Baxter Oncology GmbH
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
During an inspection of Baxter Oncology GmbH, a drug and biologics manufacturer in Halle/Westfalen, Germany, the FDA observed a deficiency related to product compatibility testing. Specifically, the firm failed to perform testing to ensure the compatibility of bottle stopper material with other materials. This indicates a potential issue with quality control processes.
- Company
- Baxter Oncology GmbH
- Product Type
- Biologics
- Person
Open in Dashboard
ID · ddb1700a-a8ff-4a53-bb34-d7a562249040